In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Galen buys Warner Chilcott in all stock deal

Executive Summary

Galen is buying fellow UK pharma company Warner Chilcott in an all-stock transaction that values Warner at $406mm on a fully diluted basis. Warner Chilcott shareholders will get 2.5 Galen shares for each Warner American Depository Share, which trade on Nasdaq. Galen shares currently trade of the London Stock Exchange but the after the merger it will file to trade on Nasdaq also.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Includes Contract
    • Full Acquisition
    • Payment Includes Stock

Related Companies

UsernamePublicRestriction

Register